Venture
Vedanta Biosciences, Inc.
Latest Form D 2024-08-05- CIK 1677878
- State MA
- Biotechnology
- 4 Form D offerings since 2019-02-05
- Total sold
- $240M
- across 4 offerings
- Rounds
- 4
- Form D offerings since 2019-02-05
- Latest round
- $119M
- 2023-05-02 · 021-480626
- Investors
- 25
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2023-05-02 · $119M
- 2019-02-05$45.4M021-332162
- 2019-09-19$8M021-349238
- 2021-08-13$68.4M021-409930
- 2023-05-02$119M021-480626
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($119M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-480626 | First filed2023-05-02 | Latest2024-08-05 | Sought$119M | Sold$119M | Investors25 | Exemptions506(b) |
| 021-409930 | First filed2021-08-13 | Latest2021-08-13 | Sought$75M | Sold$68.4M | Investors18 | Exemptions506(b) |
| 021-349238 | First filed2019-09-19 | Latest2019-09-19 | Sought$16.6M | Sold$8M | Investors4 | Exemptions506(b) |
| 021-332162 | First filed2019-02-05 | Latest2019-05-08 | Sought$50M | Sold$45.4M | Investors13 | Exemptions506(b) |
Who backs Vedanta Biosciences, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-08-05
| Name | Relationship |
|---|---|
| Bernat Olle | RelationshipExecutive Officer, Director |
| Charles Sherwood | RelationshipDirector |
| Susan Dillon | RelationshipDirector |
| Troy Ignelzi | RelationshipDirector |
| John LaMattina | RelationshipDirector |
| Bennett Shapiro | RelationshipDirector |
| Martin Heidecker | RelationshipDirector |
| Neil Tiwari | RelationshipDirector |
| Curt LaBelle | RelationshipDirector |
| Daniel Couto | RelationshipExecutive Officer |
| Jeffrey Silber | RelationshipExecutive Officer |
| Mark Mullikin | RelationshipExecutive Officer |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| FJS Consultants Limited | CRD— | Broker-dealer— | Offerings2 |
| China eCapital Partners, LLC | CRD150251 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Massachusetts (MA)
- Exemptions
- Rule 506(b)
- First filed
- 2019-02-05
- Latest filing
- 2024-08-05
Who backs Vedanta Biosciences, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗